Showcasing Nonclinical Efficacy & Toxicology Data Packages to Demonstrate IND Submission Readiness for Ophthalmic Gene Therapy Development
Time: 3:00 pm
day: Conference Day One
Details:
- Demonstrating comprehensive in vitro and in vivo efficacy studies to establish robust proof-of-concept data for IND approval
- Translating efficacy findings from rodent models to non-human primates to validate therapeutic potential in different species
- Understanding how complementary preclinical models address individual limitations to build complete nonclinical data packages
